Регистрация | Вход в службу | FAQ      [?] 

Ключевое слово diabetes [821 articles]

Recent papers classified by the tag diabetes.
  • Identification of White Adipocyte Progenitor Cells In Vivo
    Cell (02 October 2008)
    posted to progenitor precursor obesity diabetes cytokines adipose by Zephyrus on 2008-10-04 00:47:11 as **
  • Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association.
    Diabetes Care, Vol. 29, No. 5. (May 2006), pp. 1150-1159.
    by J Wolfsdorf, N Glaser, MA Sperling,
    posted to diabetes endo mellitus peds by zeigenl on 2006-11-22 17:54:47 as ** along with 1 group physiology
  • Novel genetic variations and haplotypes of hepatocyte nuclear factor 4alpha (HNF4A) found in Japanese type II diabetic patients.
    Drug Metab Pharmacokinet, Vol. 21, No. 4. (August 2006), pp. 337-346.
    posted to diabetes hnf4 mapping mutant by yevishere on 2008-01-03 23:34:21 as **
  • P2 promoter variants of the hepatocyte nuclear factor 4alpha gene are associated with type 2 diabetes in Mexican Americans.
    Diabetes, Vol. 56, No. 2. (February 2007), pp. 513-517.
    by DM Lehman, DK Richardson, CP Jenkinson, KJ Hunt, TD Dyer, RJ Leach, R Arya, HE Abboud, J Blangero, R Duggirala, MP Stern
    posted to diabetes hnf4 mapping by yevishere on 2008-01-03 23:27:56 as **
  • High frequency of T130I mutation of HNF4A gene in Mexican patients with early-onset type 2 diabetes.
    Clin Genet (19 November 2007)
    posted to diabetes hnf4 by yevishere on 2008-01-02 23:21:55 as **
  • Genegene interactions between HNF4A and KCNJ11 in predicting Type 2 diabetes in women
    Diabetic Medicine, Vol. 24, No. 11. (November 2007), pp. 1187-1191.
    by Qi, , Van Dam, , Asselbergs, , Hu,
    posted to diabetes hnf4 by yevishere on 2008-01-02 23:33:05 as **
  • Association of genetic variations near P2 promoter of the hepatocyte nuclear factor-4alpha gene and insulin secretion index in Thais.
    Acta Diabetol, Vol. 44, No. 4. (December 2007), pp. 227-232.
    posted to diabetes hnf4 by yevishere on 2008-01-02 23:36:40 as **
  • HNF4A genetic variants: role in diabetes.
    Curr Opin Clin Nutr Metab Care, Vol. 10, No. 4. (July 2007), pp. 397-402.
    posted to diabetes hnf4 review by yevishere on 2008-01-03 23:09:04 as **
  • Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue.
    Proc Natl Acad Sci U S A, Vol. 104, No. 20. (15 May 2007), pp. 8526-8531.
    by C Ying, Y Li, CH Leung, MD Robek, YC Cheng
    posted to diabetes hnf4 by yevishere on 2008-01-03 23:16:40 as **
  • Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Hum Mutat, Vol. 27, No. 9. (17 August 2006), pp. 854-869.
    by Sian Ellard, Kevin Colclough
  • Search of type 2 diabetes susceptibility gene on chromosome 20q.
    Biochem Biophys Res Commun, Vol. 357, No. 4. (15 June 2007), pp. 1100-1106.
    posted to diabetes hnf4 mapping by yevishere on 2008-01-03 23:17:32 as **
  • Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4alpha, GCK and TCF1 in patients with MODY in Israel.
    J Pediatr Endocrinol Metab, Vol. 20, No. 8. (August 2007), pp. 909-921.
    posted to diabetes hnf4 mutatant by yevishere on 2008-01-02 23:29:21 as **
  • Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.
    Nat Med, Vol. 7, No. 1. (January 2001), pp. 108-113.
    posted to diabetes parp by yedmonds on 2005-06-20 16:28:19 as *
  • Inflammation: the link between insulin resistance, obesity and diabetes.
    Trends Immunol, Vol. 25, No. 1. (January 2004), pp. 4-7.
    posted to diabetes inflammation obesity by yedmonds on 2005-06-22 21:04:17 as **
  • Implicating PARP and NAD+ depletion in type I diabetes.
    Nat Med, Vol. 5, No. 3. (March 1999), pp. 269-270.
    posted to diabetes nadnadh parp by yedmonds on 2005-06-20 21:07:54 as ***
  • A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.
    N Engl J Med, Vol. 342, No. 5. (3 February 2000), pp. 301-307.
    posted to diabetes iddm rapid_onset by yavanna on 2008-04-01 14:09:40 as **
  • 5-Lipoxygenase, but not 12/15-Lipoxygenase, Contributes to Degeneration of Retinal Capillaries in a Mouse Model of Diabetic Retinopathy.
    Diabetes (17 March 2008)
    by Rose A A Gubitosi-Klug, Ramaprasad Talahalli, Yunpeng Du, Jerry L L Nadler, Timothy S S Kern
    posted to 5-lox angiogenesis diabetes by YamaPing on 2008-03-31 03:22:34 as **
  • Role of advanced glycation end products in diabetic neuropathy.
    Current pharmaceutical design, Vol. 14, No. 10. (2008), pp. 953-961.
    posted to age diabetes by YamaPing on 2008-05-15 05:45:08 as **
  • A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene
    Nature (15 July 2007)
    by Hakon Hakonarson, Struan FA Grant, Jonathan P Bradfield, Luc Marchand, Cecilia E Kim, Joseph T Glessner, Rosemarie Grabs, Tracy Casalunovo, Shayne P Taback, Edward C Frackelton, Margaret L Lawson, Luke J Robinson, Robert Skraban, Yang Lu, Rosetta M Chiavacci, Charles A Stanley, Susan E Kirsch, Eric F Rappaport, Jordan S Orange, Dimitri S Monos, Marcella Devoto, Hui-Qi Qu, Constantin Polychronakos
    posted to diabetes gwa by xingxu on 2007-08-01 21:38:05 as ***
  • Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
    Nature Genetics, Vol. 39, No. 2. (07 January 2007), pp. 218-225.
    by Agnar Helgason, Snæbjörn Pálsson, Gudmar Thorleifsson, Struan FA Grant, Valur Emilsson, Steinunn Gunnarsdottir, Adebowale Adeyemo, Yuanxiu Chen, Guanjie Chen, Inga Reynisdottir, Rafn Benediktsson, Anke Hinney, Torben Hansen, Gitte Andersen, Knut Borch-Johnsen, Torben Jorgensen, Helmut Schäfer, Mezbah Faruque, Ayo Doumatey, Jie Zhou, Robert L Wilensky, Muredach P Reilly, Daniel J Rader, Yu Bagger, Claus Christiansen, Gunnar Sigurdsson, Johannes Hebebrand, Oluf Pedersen, Unnur Thorsteinsdottir, Jeffrey R Gulcher, Augustine Kong, Charles Rotimi, Kári Stefansson
    posted to decode diabetes evolution by xingxu on 2007-08-17 16:46:47 as ** along with 2 people joepickrell caseybrown
  • Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.
    Stroke, Vol. 32, No. 10. (October 2001), pp. 2426-2432.
    by SE Capes, D Hunt, K Malmberg, P Pathak, HC Gerstein
    posted to diabetes me by worx11 on 2007-08-15 16:55:25 as *** along with 1 group XROWXR
  • Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum.
    J Hosp Med, Vol. 2, No. 4. (July 2007), pp. 203-211.
    by CB Cook, JC Castro, RE Schmidt, SM Gauthier, MD Whitaker, LR Roust, R Argueta, BP Hull, RS Zimmerman
    posted to diabetes hospital me by worx11 on 2007-10-10 14:43:44 as ** along with 1 group XROWXR
  • Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.
    Lancet, Vol. 355, No. 9206. (4 March 2000), pp. 773-778.
    by SE Capes, D Hunt, K Malmberg, HC Gerstein
    posted to diabetes economic me by worx11 on 2007-08-15 16:53:32 as *** along with 1 group XROWXR
  • The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Ann Intern Med, Vol. 142, No. 5. (1 March 2005), pp. 323-332.
    by WH Herman, TJ Hoerger, M Brandle, K Hicks, S Sorensen, P Zhang, RF Hamman, RT Ackermann, MM Engelgau, RE Ratner
  • Efficacy and safety of insulin glulisine in patients with type 1 diabetes.
    Horm Metab Res, Vol. 37, No. 11. (November 2005), pp. 702-707.
    posted to diabetes me by worx11 on 2007-08-17 19:44:13 as *** along with 1 group XROWXR
  • Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    JAMA, Vol. 276, No. 17. (6 November 1996), pp. 1409-1415.
    posted to diabetes economic me by worx11 on 2007-08-16 16:10:10 as *** along with 1 group XROWXR
  • Lifetime costs of complications resulting from type 2 diabetes in the U.S.
    Diabetes Care, Vol. 25, No. 3. (March 2002), pp. 476-481.
    by JJ Caro, AJ Ward, JA O'Brien
  • Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes.
    Diabetes Care, Vol. 22, No. 9. (September 1999), pp. 1408-1414.
    posted to diabetes economic me by worx11 on 2007-08-18 17:41:24 as *** along with 1 group XROWXR
  • Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis.
    Diabet Med, Vol. 20, No. 10. (October 2003), pp. 863-866.
    by J Colquitt, P Royle, N Waugh
    posted to diabetes me by worx11 on 2007-08-16 14:56:30 as *** along with 1 group XROWXR
  • [Health care costs of persons with diabetes prior to and following hospitalization in Argentina]
    Rev Panam Salud Publica, Vol. 20, No. 6. (December 2006), pp. 361-368.
    posted to cost-effectiveness diabetes zt by worx11 on 2007-09-12 16:02:01 as ** along with 1 group XROWXR
  • Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke.
    Neurology, Vol. 59, No. 1. (9 July 2002), pp. 67-71.
    by LS Williams, J Rotich, R Qi, N Fineberg, A Espay, A Bruno, SE Fineberg, WR Tierney
    posted to diabetes economic me by worx11 on 2007-08-22 18:19:58 as *** along with 1 group XROWXR
  • The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.
    Health Technol Assess, Vol. 11, No. 33. (September 2007), pp. 1-126.
    by C Black, E Cummins, P Royle, S Philip, N Waugh
    posted to cost-effectiveness diabetes zt by worx11 on 2007-09-12 15:56:17 as ** along with 1 group XROWXR
  • New strategies in insulin treatment: analogues and noninvasive routes of administration
    Fundamental & Clinical Pharmacology, Vol. 19, No. 2. (April 2005), pp. 127-132.
    by Rungby Jorgen, Brock Birgitte, Schmitz Ole
    posted to diabetes me by worx11 on 2007-08-21 19:12:28 as *** along with 1 group XROWXR
  • Evolving natural history of coronary artery disease in diabetes mellitus.
    Am J Med, Vol. 90, No. 2A. (21 February 1991)
    by AS Krolewski, JH Warram, P Valsania, BC Martin, LM Laffel, AR Christlieb
    posted to diabetes me by worx11 on 2007-08-21 01:55:26 as *** along with 1 group XROWXR
  • Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.
    Diabetes Care, Vol. 28, No. 6. (June 2005), pp. 1282-1288.
  • Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology, Vol. 102, No. 4. (April 1995), pp. 647-661.
    posted to diabetes me by worx11 on 2007-08-17 19:09:33 as *** along with 1 group XROWXR
  • Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.
    Mayo Clin Proc, Vol. 78, No. 12. (December 2003), pp. 1471-1478.
    by JS Krinsley
    posted to diabetes me by worx11 on 2007-08-21 01:54:08 as *** along with 1 group XROWXR
  • [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.
    Diabetes, Vol. 43, No. 3. (March 1994), pp. 396-402.
    by DC Howey, RR Bowsher, RL Brunelle, JR Woodworth
    posted to diabetes me by worx11 on 2007-08-18 19:10:57 as *** along with 1 group XROWXR
  • Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
    Circulation, Vol. 112, No. 17. (25 October 2005), pp. 2735-2752.
    by SM Grundy, JI Cleeman, SR Daniels, KA Donato, RH Eckel, BA Franklin, DJ Gordon, RM Krauss, PJ Savage, SC Smith, JA Spertus, F Costa
  • Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Clin Ther, Vol. 23, No. 10. (October 2001), pp. 1732-1744.
    posted to diabetes me by worx11 on 2007-08-21 18:31:20 as *** along with 1 group XROWXR
  • Insulin therapy in type 2 diabetes.
    Endocrinol Metab Clin North Am, Vol. 30, No. 4. (December 2001), pp. 935-982.
    by S Mudaliar, SV Edelman
    posted to diabetes glargine me by worx11 on 2007-08-21 03:15:23 as *** along with 1 group XROWXR
  • When oral agents fail: practical barriers to starting insulin.
    Int J Obes Relat Metab Disord, Vol. 26 Suppl 3 (September 2002)
    posted to diabetes me by worx11 on 2007-08-21 01:14:06 as *** along with 1 group XROWXR
  • Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association.
    Diabetes Care, Vol. 29, No. 7. (July 2006), pp. 1697-1699.
    by RH Eckel, R Kahn, RM Robertson, RA Rizza
    posted to bm cmrf diabetes jmcp_manuscript by worx11 on 2007-07-31 15:44:41 as ***** along with 1 group XROWXR
  • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
    N Engl J Med, Vol. 339, No. 4. (23 July 1998), pp. 229-234.
    posted to diabetes me by worx11 on 2007-08-18 18:27:52 as *** along with 1 group XROWXR
  • Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.
    Am Fam Physician, Vol. 70, No. 3. (1 August 2004), pp. 489-500.
    by JA Mayfield, RD White
    posted to diabetes me by worx11 on 2007-08-21 02:48:57 as *** along with 1 group XROWXR
  • Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.
    JAMA, Vol. 289, No. 17. (7 May 2003), pp. 2265-2269.
    by DE Dewitt, DC Dugdale
    posted to diabetes economic me by worx11 on 2007-08-17 19:24:40 as *** along with 1 group XROWXR
  • Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
    Diabetes Care, Vol. 26, No. 1. (January 2003), pp. 1-8.
    by C Levetan, LL Want, C Weyer, SA Strobel, J Crean, Y Wang, DG Maggs, OG Kolterman, M Chandran, SR Mudaliar, RR Henry
    posted to diabetes me by worx11 on 2007-08-21 02:28:00 as *** along with 1 group XROWXR
  • The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.
    Arch Intern Med, Vol. 163, No. 4. (24 February 2003), pp. 427-436.
  • Undiagnosed diabetes or impaired glucose tolerance and cardiovascular risk.
    Diabetes Care, Vol. 20, No. 2. (February 1997), pp. 127-128.
    by RC Eastman, CC Cowie, MI Harris
    posted to diabetes me by worx11 on 2007-08-17 19:50:28 as *** along with 1 group XROWXR
  • Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.
    Diabetes Care, Vol. 21, No. 10. (October 1998), pp. 1726-1731.
    by BL Brunelle, J Llewelyn, JH Anderson, EA Gale, VA Koivisto
    posted to diabetes me by worx11 on 2007-08-15 16:16:38 as *** along with 1 group XROWXR
  • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/tag/diabetes

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.